ABEONA THERAPEUTICS INC. — Income Charts
16 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+94.0% +$3M
$6M
Cost of Revenue
$2M
R&D↓-30.8% -$12M
$27M
SG&A
$65M
D&A↓-21.6% -$701K
$3M
Operating Income↑+0.4% +$388K
$-89M
EBITDA↓-0.4% -$313K
$-87M
Interest Expense↑+2.3% +$84K
$4M
Interest Income↑+13790.0% +$6M
$6M
Other Income/Expense
$159M
Pretax Income
$71M
Tax Provision
$100K
Net Income↑+183.8% +$156M
$71M
Operating Margin↑+1457.6pts
-1536.9%
Net Margin↑+4054.3pts
1223.1%
Effective Tax Rate
0.1%
Deferred Tax Assets
$2M
Deferred Tax Liabilities
$2M
DTA Valuation Allowance↓-16.5% -$15M
$75M
NOL Carryforwards↓-83.7% -$59M
$12M
ETR (Continuing Operations)
0.1%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
Operating Lease Cost↓-20.4% -$360K
$1M
Revenue YoY Variation
147.5%
Income YoY Variation↓-29.0pts
-39.3%